Wood, David – consultant physician and clinical toxicologist

 

Consultant profiles

David Wood, consultant physician and clinical toxicologist

Contacts

Secretary tel: 020 7188 5848
Email: barbara.whetton@gstt.nhs.uk 

Area of expertise: recreational drugs, new psychoactive substances, prescription medicine misuse and toxicity, heavy metal toxicity, cardiovascular drug toxicity and paracetamol toxicity

  • Biography

    David Wood is a consultant physician and clinical toxicologist at Guy's and St Thomas' and reader in clinical toxicology at King’s College London.

    He has a clinical, research and academic interest in epidemiology of use of and acute harms related to recreational drugs, new psychoactive substances (NPS) and misused prescription medicines.

    He is a co-opted member of the UK Advisory Council on the Misuse of Drugs (ACMD) and expert advisor to the European Monitoring Centre for Drugs and Drug Addiction (ECMDDA), World Health Organisation (WHO) and United Nations Office on Drugs and Crime (UNODC) in the area of recreational drugs and NPS.

  • Education/training

    • University of Bristol, BSc 1st class hons in pharmacology, 1994
    • University of Bristol, MB ChB (hons), 1997
    • Royal College of Physicians, MRCP, 2000
    • University of London MD, 2005
    • Certificate of completion of specialist training in general (internal) medicine and clinical pharmacology and therapeutics, 2007
  • Specialist interests

    • Recreational drug and new psychoactive substance toxicity
    • Prescription medicine misuse and toxicity
    • Contaminated cabin air ('aerotoxic syndrome')
    • Heavy metal toxicity
    • Cardiovascular drug toxicity management
    • Paracetamol toxicity and treatment management options
  • Awards

    David has been awarded fellowships by:

    • British Pharmacological Society (FBPhS), 2012
    • Royal College of Physicians (FRCP), 2012
    • American College of Medical Toxicology (FACMT), 2012
    • European Association of Poisons Centres and Clinical Toxicologist (FEAPCCT), 2015
    • American Academy of Clinical Toxicology (FAACT), 2018
  • Research interests

    • Epidemiology of and acute harms related to misuse of recreational drugs

    • New psychoactive substances and prescription medicine, and the related acute harms to this use/misuse. This is delivered in through the European Drug Emergency Network (Euro-DEN)

    • Project and collaborative work with the US RADARS system